Vanberra Signal
Free trial

Opsisdx

Curated by Signal

Provider of the multi-disease diagnostic platform

Health Technologyopsisdx.com

Overview

Provider of the multi-disease diagnostic platform. The company's first test is the OpsisDx Prostate Cancer Test, which is a non-invasive test that relies on a proprietary molecular profile combined with novel machine learning algorithms to determine prostate cancer detection from the biopsy. The test does not require a digital rectal exam and does not rely on nucleic acids or other predefined biomarkers to assess health status. It also offers diagnostic solutions to Liver cancer.

Key facts

Founded
2017
Headquarters
United States
Stage
Sign up to view
Industry
Health Technology

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • GuidePTTM

    Provider of a digital solutions for patient care leveraging physical therapists expertise

    Health TechnologyBethesda, United States

  • Issio solutions

    Cloud based EMR platform for Ambulatory Surgery Centres (ASC)

    Health TechnologyOakland, United States

  • MMJ Doctor

    Provides online medical marijuana card

    Health TechnologySan Francisco, United States

About Opsisdx

What does Opsisdx do?

Provider of the multi-disease diagnostic platform.

Where is Opsisdx headquartered?

Opsisdx is headquartered in United States.

When was Opsisdx founded?

Opsisdx was founded in 2017.

Which sector is Opsisdx in?

Opsisdx operates in Health Technology.

Who are Opsisdx's competitors?

Companies similar to Opsisdx include GuidePTTM, Issio solutions, and MMJ Doctor.